September 25, 2017
RegMed Investors’ (RMi) pre-open indications; there is a season (turn, turn, turn) and a time to every purpose, under heaven
September 22, 2017
RegMed Investors’ (RMi) pre-open indications; pricing hunkers down
September 21, 2017
RegMed Investors’ (RMi) pre-open indications; there exists a fundamental mistrust
September 20, 2017
RegMed Investors’ (RMi) pre-open indications; who is “our” rocket man or woman CEO
September 19, 2017
RegMed Investors’ (RMi) pre-open indications; anticipating vulnerability in a sector of coincidental risk
September 18, 2017
RegMed Investors’ (RMi) pre-open indications; alternating positions
September 15, 2017
RegMed Investors’ (RMi) pre-open indications; Our universe is pulsing on momentum which can easily dissipate
September 14, 2017
RegMed Investors’ (RMi) pre-open indications; what revelations are due today?
September 13, 2017
RegMed Investors’ (RMi) pre-open indications; do the weak get weaker?
September 12, 2017
RegMed Investors’ (RMi) pre-open indications; achieving appreciation ain’t easy
September 11, 2017
RegMed Investors’ (RMi) pre-open indications; there’s no escape
September 8, 2017
RegMed Investors’ (RMi) pre-open indications; long or gone over this weekend
September 7, 2017
RegMed Investors’ (RMi) pre-open indications, even expectation is in the air
September 6, 2017
RegMed Investors’ (RMi) pre-open indications, looking down the barrel at a shot-up sector
September 5, 2017
RegMed Investors’ (RMi) pre-open indications, some high premiums since 8/17/17
September 1, 2017
RegMed Investors’ (RMi) pre-open indications, keep an eye on the indexes and averages
August 31, 2017
RegMed Investors’ (RMi) pre-open indications, I continue to worry
August 30, 2017
RegMed Investors’ (RMi) pre-open indications, probability is my key word
August 29, 2017
RegMed Investors’ (RMi) pre-open indications, expect a reversal
August 28, 2017
RegMed Investors’ (RMi) pre-open indications, Gilead Sciences (GILD) buys Kite Pharma in all cash deal
August 25, 2017
RegMed Investors’ (RMi) pre-open indications, the sector’s seesaw action can take a toll
August 24, 2017
RegMed Investors’ (RMi) pre-open indications, it’s not worth trading on pennies
August 23, 2017
RegMed Investors’ (RMi) pre-open indications, watch your corners
August 22, 2017
RegMed Investors’ (RMi) pre-open indications, yesterday you drunk the humpty-dumpty
August 21, 2017
RegMed Investors’ (RMi) pre-open indications, glad last week is over
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.